Journal
PHARMACOLOGY
Volume 88, Issue 3-4, Pages 188-192Publisher
KARGER
DOI: 10.1159/000330739
Keywords
Transforming growth factor-beta; Collagen type IV; Mesangial cells, rat; Diabetic nephropathy; Simvastatin; p38 mitogen-activated protein kinase
Categories
Funding
- Education Department of Heilongjiang Province [11551197]
Ask authors/readers for more resources
Objective: Diabetic nephropathy is characterized by the accumulation of extracellular matrix in the glomerular mesangium as a result of an imbalance between matrix synthesis and degradation. Since simvastatin has been proposed to decrease renal interstitial fibrosis, we hypothesized that the protective effect of statins was related to the expression of transforming growth factor-beta (TGF-beta) and type IV collagen (Col IV). Methods: Cultured rat mesangial cells (RMC) were exposed to high glucose (HG), advanced glycosylation end products (AGE) or H(2)O(2) in the absence and presence of simvastatin. Expression of TGF-beta and Col IV was determined by Western blotting. Results: Coincubation of RMC with HG, AGE or H(2)O(2) resulted in a significant increase of the expression of TGF-beta and Col IV (p < 0.05). Simvastatin significantly inhibited HG-, AGE- or H(2)O(2)-induced expression of TGF-beta and Col IV (p < 0.05). Moreover, simvastatin also inhibited HG-, AGE-and H(2)O(2)-induced activation of p38 mitogen-activated protein kinase, which indicated that the preventive effect of simvastatin on TGF-beta and Col IV may be associated with p38. Conclusion: These findings suggest that simvastatin can reduce HG-, AGE- and H(2)O(2)-induced expression of TGF-beta and Col IV by inhibition of the p38 pathway. Copyright (C) 2011 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available